Involvement of Ca2+-induced Ca2+ releasing system in interleukin-1β-associated adenosine release

European Journal of Pharmacology

Volumn 532, Issue 3, 2006, Pages 246-252

  Zhu, Gang ^a   Okada, Motohiro ^a   Yoshida, Shukuko ^a,b   Mori, Fumiaki ^a   Hirose, Shinichi ^c   Wakabayashi, Koichi ^a   Kaneko, Sunao ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b Institute of Neuroscience and Molecular Biology   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

Author keywords

Adenosine; Ca2+ induced Ca2+ releasing system; Hippocampus; Interleukin 1 ; Neurodegeneration; Neuroprotection

Indexed keywords

ADENOSINE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; POTASSIUM ION; RECOMBINANT INTERLEUKIN 1BETA; RYANODINE RECEPTOR;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; HIPPOCAMPUS; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE; ANIMALS; CALCIUM; CALCIUM CHANNELS; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MACROCYCLIC COMPOUNDS; MALE; MICE; MICE, INBRED C57BL; OXAZOLES; POTASSIUM; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, INTERLEUKIN-1; RUTHENIUM RED; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SIALOGLYCOPROTEINS;

EID: 33644558343     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.12.085     Document Type: Article

References (51)

1. P.D. Arora, J. Ma, W. Min, T. Cruz, and C.A. McCulloch Interleukin-1-induced calcium flux in human fibroblasts is mediated through focal adhesions J. Biol. Chem. 270 1995 6042 6049
2. M.J. Berridge Neuronal calcium signaling Neuron 21 1998 13 26
3. S. Blackshaw, A. Sawa, A.H. Sharp, C.A. Ross, S.H. Snyder, and A.A. Khan Type 3 inositol 1,4,5-trisphosphate receptor modulates cell death FASEB J. 14 2000 1375 1379
4. P.G. Bradford, J.M. Maglich, and K.L. Kirkwood IL-1 beta increases type 1 inositol trisphosphate receptor expression and IL-6 secretory capacity in osteoblastic cell cultures Mol. Cell. Biol. Res. Commun. 3 2000 73 75
5. 2+ entry differentially contribute to the release of IL-1 beta and IL-1 alpha from murine macrophages J. Immunol. 170 2003 3029 3036
6. F. Casamenti, C. Prosperi, C. Scali, L. Giovannelli, M.A. Colivicchi, M.S. Faussone-Pellegrini, and G. Pepeu Interleukin-1beta activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer's disease Neuroscience 91 1999 831 842
7. 7 receptor channels J. Neurosci. 22 2002 3061 3069
8. C.A. Dinarello Biology of interleukin 1 FASEB J. 2 1988 108 115
9. W.L. Farrar, P.L. Kilian, M.R. Ruff, J.M. Hill, and C.B. Pert Visualization and characterization of interleukin 1 receptors in brain J. Immunol. 139 1987 459 463
10. W.S. Griffin, L.C. Stanley, C. Ling, L. White, V. MacLeod, L.J. Perrot, C.L. White III, and C. Araoz Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 86 1989 7611 7615
11. +- and glutamate-evoked release of endogenous adenosine from rat cortical slices J. Neurochem. 54 1990 256 265
12. H. Kamikawa, T. Hori, H. Nakane, S. Aou, and N. Tashiro IL-1beta increases norepinephrine level in rat frontal cortex: involvement of prostanoids, NO, and glutamate Am. J. Physiol. 275 1998 R803 R810
13. K. Kanemoto, J. Kawasaki, T. Miyamoto, H. Obayashi, and M. Nishimura Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy Ann. Neurol. 47 2000 571 574
14. +-evoked serotonin release Br. J. Pharmacol. 133 2001 557 567
15. J.M. Krueger, S. Takahashi, L. Kapas, S. Bredow, R. Roky, J. Fang, R. Floyd, K.B. Renegar, N. Guha-Thakurta, S. Novitsky, and S. Obal Cytokines in sleep regulation Adv. Neuroimmunol. 5 1995 171 188
16. S. Latini, and F. Pedata Adenosine in the central nervous system: release mechanisms and extracellular concentrations J. Neurochem. 79 2001 463 484
17. 7 receptors in neurodegeneration Eur. J. Pharmacol. 447 2002 261 269
18. S.A. Loddick, C. Liu, T. Takao, K. Hashimoto, and E.B. De Souza Interleukin-1 receptors: cloning studies and role in central nervous system disorders Brain Res. Brain Res. Rev. 26 1998 306 319
19. W.P. Luk, Y. Zhang, T.D. White, F.A. Lue, C. Wu, C.G. Jiang, L. Zhang, and H. Moldofsky Adenosine: a mediator of interleukin-1beta-induced hippocampal synaptic inhibition J. Neurosci. 19 1999 4238 4244
20. 2+ release in human astrocytoma U-373 MG cells and brain striatal slices J. Neurosci. 20 2000 8980 8986
21. M. Mogi, M. Harada, T. Kondo, P. Riederer, H. Inagaki, M. Minami, and T. Nagatsu Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients Neurosci. Lett. 180 1994 147 150
22. F. Mori, M. Okada, M. Tomiyama, S. Kaneko, and K. Wakabayashi Effects of ryanodine receptor activation on neurotransmitter release and neuronal cell death following kainic acid-induced status epileptics Epilepsy Res. 65 2005 59 70
23. F. Nakatsu, M. Okada, F. Mori, N. Kumazawa, H. Iwasa, G. Zhu, Y. Kasagi, H. Kamiya, A. Harada, K. Nishimura, A. Takeuchi, T. Miyazaki, M. Watanabe, S. Yuasa, T. Manabe, K. Wakabayashi, S. Kaneko, T. Saito, and H. Ohno Defective function of GABA-containing synaptic vesicles in mice lacking the AP-3B clathrin adaptor J. Cell Biol. 167 2004 293 302
24. 7 receptor expression and function in human astrocytes Glia 49 2005 245 258
25. M. Okada, Y. Kawata, K. Kiryu, K. Mizuno, K. Wada, H. Tasaki, and S. Kaneko Effects of adenosine receptor subtypes on hippocampal extracellular serotonin level and serotonin reuptake activity J. Neurochem. 69 1997 2581 2588
26. 2+ channel antagonists on striatal dopamine and DOPA release, studied by in vivo microdialysis Br. J. Pharmacol. 123 1998 805 814
27. M. Okada, D.J. Nutt, T. Murakami, G. Zhu, A. Kamata, Y. Kawata, and S. Kaneko Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release J. Neurosci. 21 2001 628 640
28. M. Okada, G. Zhu, S. Hirose, K.I. Ito, T. Murakami, M. Wakui, and S. Kaneko Age-dependent modulation of hippocampal excitability by KCNQ-channels Epilepsy Res. 53 2003 81 94
29. M.R. Opp, and J.M. Krueger Interleukin 1-receptor antagonist blocks interleukin 1-induced sleep and fever Am. J. Physiol. 260 1991 R453 R457
30. M. Oprica, C. Eriksson, and M. Schultzberg Inflammatory mechanisms associated with brain damage induced by kainic acid with special reference to the interleukin-1 system J. Cell. Mol. Med. 7 2003 127 140
31. D.L. Palazzolo, and S.K. Quadri Interleukin-1 stimulates catecholamine release from the hypothalamus Life Sci. 47 1990 2105 2109
32. W. Paschen, and A. Frandsen Endoplasmic reticulum dysfunction-a common denominator for cell injury in acute and degenerative diseases of the brain? J. Neurochem. 79 2001 719 725
33. H.C. Patel, H. Boutin, and S.M. Allan Interleukin-1 in the brain: mechanisms of action in acute neurodegeneration Ann. N.Y. Acad. Sci. 992 2003 39 47
34. M.R. Pelletier, J.S. Wadia, L.R. Mills, and P.L. Carlen Seizure-induced cell death produced by repeated tetanic stimulation in vitro: possible role of endoplasmic reticulum calcium stores J. Neurophysiol. 81 1999 3054 3064
35. I. Pita, A.M. Jelaso, and C.F. Ide IL-1beta increases intracellular calcium through an IL-1 type 1 receptor mediated mechanism in C6 astrocytic cells Int. J. Dev. Neurosci. 17 1999 813 820
36. A.C. Radesater, S. Johansson, C. Oberg, and J. Luthman The vitamin-E analog trolox and the NMDA antagonist MK-801 protect pyramidal neurons in hippocampal slice cultures from IL-1beta-induced neurodegeneration Neurotox. Res. 5 2003 433 442
37. 2+-triggered exocytosis Science 298 2002 781 785
38. N.J. Rothwell, and G.N. Luheshi Interleukin 1 in the brain: biology, pathology and therapeutic target Trends Neurosci. 23 2000 618 625
39. H. Schneider, F. Pitossi, D. Balschun, A. Wagner, A. del Rey, and H.O. Besedovsky A neuromodulatory role of interleukin-1beta in the hippocampus Proc. Natl. Acad. Sci. U.S.A. 95 1998 7778 7783
40. T. Sollner, M.K. Bennett, S.W. Whiteheart, R.H. Scheller, and J.E. Rothman A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion Cell 75 1993 409 418
41. B. Sperlagh, M. Baranyi, G. Hasko, and E.S. Vizi Potent effect of interleukin-1 beta to evoke ATP and adenosine release from rat hippocampal slices J. Neuroimmunol. 151 2004 33 39
42. P.J. Strijbos, and N.J. Rothwell Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor J. Neurosci. 15 1995 3468 3474
43. T.C. Sudhof The synaptic vesicle cycle: a cascade of protein-protein interactions Nature 375 1995 645 653
44. 2+ signalling: problems and pitfalls Trends Pharmacol. Sci. 19 1998 370 375
45. M. Tymianski, M.P. Charlton, P.L. Carlen, and C.H. Tator Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons J. Neurosci. 13 1993 2085 2104
46. A. Vezzani, D. Moneta, C. Richichi, M. Aliprandi, S.J. Burrows, T. Ravizza, C. Perego, and M.G. De Simoni Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis Epilepsia 43 Suppl 5 2002 30 35
47. L. Vitkovic, J. Bockaert, and C. Jacque "Inflammatory" cytokines: neuromodulators in normal brain? J. Neurochem. 74 2000 457 471
48. 2+ from internal stores is dependent on cell-matrix interactions and regulates ERK activation FASEB J. 17 2003 1898 1900
49. 2+-release signal transduction pathway in mesangial cells Am. J. Physiol., Renal Fluid Electrolyte Physiol. 281 2001 F91 F102
50. G. Zhu, M. Okada, D. Uchiyama, T. Ohkubo, S. Yoshida, and S. Kaneko Hyperactivity of endoplasmic reticulum associated exocytosis mechanism contributes to acute phencyclidine intoxication J. Pharmacol. Sci. 95 2004 214 227
51. 2+ releasing system in rat striatum Neurosci. Lett. 362 2004 244 248